Sensitive ASX Announcement

Telix and GenesisCare Commence Prostate Cancer Study

Published: 08/08/19, 08:24am (AEST)3 pages
Telix Pharmaceuticals Limited
TLX:ASXHealthcare

Recent TLX Announcements

Price Sensitive only